EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)VergleichsstudieMultizentrische StudieRandomisierte kontrollierte StudieOpen Access

Acute Declines in Estimated Glomerular Filtration Rate in Patients Treated With Benazepril and Hydrochlorothiazide Versus Amlodipine and Risk of Cardiovascular Outcomes

Elaine Ku iD, Kenneth Jamerson iD, Timothy P Copeland iD, Charles E McCulloch iD, Hocine Tighiouart iD, Mark J Sarnak

Journal of the American Heart Association · 06.08.2024 · 13 (15)

DOI: 10.1161/jaha.124.035177 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Journal of the American Heart Association, erschienen am 06.08.2024. Verfasst von Elaine Ku und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine University of California San Francisco CA. Hauptthemen laut MEDLINE: Amlodipine, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Benzazepines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Acute declines in estimated glomerular filtration rate (eGFR) occur commonly after starting angiotensin‐converting enzyme inhibitors. Whether declines in eGFR that occur after simultaneously starting angiotensin‐converting enzyme inhibitors with other antihypertensive agents modifies the benefits of these agents on cardiovascular outcomes is unclear. Methods and Results We identified predictors of acute declines in eGFR (>15% over 3 months) during randomization to benazepril plus amlodipine versus benazepril plus hydrochlorothiazide in the ACCOMPLISH (Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension) trial. We then determined the relation between declines in eGFR (treated as a binary variable, ≤15% versus >15% and separately, as a restricted spline variable) and the composite risk of fatal and nonfatal cardiovascular events using Cox proportional hazards models. We included 10 714 participants (median age 68 years [Q1 63, Q3 73]), of whom 1024 reached the trial end point over median follow‐up of 2.8 years. Predictors of acute declines in eGFR>15% over 3 months included assignment to hydrochlorothiazide (versus amlodipine) and higher baseline albuminuria. Overall, declines in eGFR ≥15% (versus

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmlodipineAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsBenzazepinesDrug Therapy, CombinationGlomerular Filtration RateHydrochlorothiazideHypertensionAgedFemaleHumansMaleMiddle AgedCalcium Channel BlockersCardiovascular DiseasesKidneyRisk AssessmentRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

antihypertensive therapycardiovascular diseasehypertension

Substanzen

AmlodipineAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsbenazeprilBenzazepinesCalcium Channel BlockersHydrochlorothiazide

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine University of California San Francisco CA.
  • Department of Epidemiology & Biostatistics University of California San Francisco CA.
  • Department of Medicine, Division of Cardiovascular Medicine University of Michigan Ann-Arbor Ann-Arbor MI.
  • Institute for Clinical Research and Health Policy Studies Tufts Medical Center Boston MA.
  • Tufts Clinical and Translational Science Institute Tufts University Boston MA.
  • Division of Nephrology, Department of Medicine Tufts University Boston MA.

ORCID-Profile: Elaine Ku, Kenneth Jamerson, Timothy P Copeland, Charles E McCulloch, Hocine Tighiouart

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Ku, E., Jamerson, K., Copeland, T. P., McCulloch, C. E., Tighiouart, H., & Sarnak, M. J. (2024). Acute Declines in Estimated Glomerular Filtration Rate in Patients Treated With Benazepril and Hydrochlorothiazide Versus Amlodipine and Risk of Cardiovascular Outcomes. Journal of the American Heart Association, 13(15). https://doi.org/10.1161/jaha.124.035177

Vancouver

Ku E, Jamerson K, Copeland TP, McCulloch CE, Tighiouart H, Sarnak MJ. Acute Declines in Estimated Glomerular Filtration Rate in Patients Treated With Benazepril and Hydrochlorothiazide Versus Amlodipine and Risk of Cardiovascular Outcomes. Journal of the American Heart Association. 2024;13(15). doi:10.1161/jaha.124.035177

BibTeX
@article{Ku2024,
  author = {Ku, Elaine and Jamerson, Kenneth and Copeland, Timothy P and McCulloch, Charles E and Tighiouart, Hocine and Sarnak, Mark J},
  title = {Acute Declines in Estimated Glomerular Filtration Rate in Patients Treated With Benazepril and Hydrochlorothiazide Versus Amlodipine and Risk of Cardiovascular Outcomes},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {15},
  doi = {10.1161/jaha.124.035177}
}
Kostenlos starten →